Phendimetrazine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Phendimetrazine. Educational only — not medical advice.

Labeled uses

Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follow: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. BODY MASS INDEX (BMI), kg/m 2 Height (feet, inches) | Weight | 5’0” | 5’3” | 5’6” | 5’9” | 6’0” | 6’3” | (pounds) | | | | | | | 140 | 27 | 25 | 23 | 21 | 19 | 18 | 150 | 29 | 27 | 24 | 22 | 20 | 19 | 160 | 31 | 28 | 26 | 24 | 22 | 20 | 170 | 33 | 30 | 28 | 25 | 23 | 21 | 180 | 35 | 32 | 29 | 27 | 25 | 23 | 190 | 37 | 34 | 31 | 28 | 26 | 24 | 200 | 39 | 36 | 32 | 30 | 27 | 25 | 210 | 41 | 37 | 34 | 31 | 29 | 26 | 220 | 43 | 39 | 36 | 33 | 30 | 28 | 230 | 45 | 41 | 37 | 34 | 31 | 29 | 240 | 47 | 43 | 39 | 36 | 33 | 30 | 250 | 49 | 44 | 40 | 37 | 34 | 31 |   Phendimetraz…

Source: FDA labeling via NIH DailyMed (set 05bb0569…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.